Vigil Neuroscience, Inc.
6.10%
2,842,000
1827087
92673K108
Jun 4, 2025
Jun 9, 2025, 05:48 PM
Reporting Persons (3)
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Vida Ventures III, L.P. | Partnership | 6.10% | 2,835,464 | 0 | 2,835,464 |
| Vida Ventures GP III, L.L.C. | Other | 6.10% | 2,842,000 | 0 | 2,842,000 |
| Vida Ventures III-A, L.P. | Partnership | 0.00% | 6,536 | 0 | 6,536 |
Disclosure Items (6)
Common Stock, $0.0001 par value per share
Vigil Neuroscience, Inc.
100 Forge Road, Watertown, MA, 02472
This Amendment is being filed by Vida III, Vida III-A, and Vida III GP (each as defined in the Original 13D) and together with Vida III and Vida III-A, the "Reporting Persons")). Stefan Vitorovic, a reporting person on the Original 13D, is no longer a member of Vida III GP, and accordingly, is no longer a Reporting Person. The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13D. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached to the Original 13D as Exhibit 1 thereto. Other than those securities reported herein as being held directly by such Reporting Person, each Reporting Person disclaims beneficial ownership of all securities reported in this Amendment except to the extent of such Reporting Person's pecuniary interest therein.
The information set forth in Item 2(b) of the Original Schedule 13D is incorporated herein by reference.
The information set forth in Item 2(c) of the Original Schedule 13D is incorporated herein by reference.
The information set forth in Item 2(e) of the Original Schedule 13D is incorporated herein by reference.
The information set forth in Item 2(f) of the Original Schedule 13D is incorporated herein by reference.
The information set forth in Item 3 of the Original Schedule 13D is incorporated herein by reference.
See Items 7-11 of the cover pages of this Amendment No. 2. The information reported on such cover pages is reported as of June 6, 2025.
See Items 7-11 of the cover pages of this Amendment No. 2. The information reported on such cover pages is reported as of June 6, 2025.
On June 5, 2025, Vida III sold 594,558 shares of Common Stock at a weighted average price per share of $7.8838 for aggregate proceeds of $4,687,386.65. On June 5, 2025, Vida III-A sold 1,371 shares of Common Stock at a weighted average price per share of $7.8838 for aggregate proceeds of $10,805.25. On June 6, 2025, Vida III sold 1,574,371 shares of Common Stock at a weighted average price per share of $7.8755 for aggregate proceeds of $12,398,957.24. On June 6, 2025, Vida III-A sold 3,629 shares of Common Stock at a weighted average price per share of $7.8755 for aggregate proceeds of $28,581.76.
The information set forth in Item 5(d) of the Original Schedule 13D is incorporated herein by reference.
N/A
The information set forth in Item 6 of the Original Schedule 13D is incorporated herein by reference.